Citi Reduces PT on GE HealthCare Technologies (GEHC) Stock

robot
Abstract generation in progress

Citi has reduced its price target for GE HealthCare Technologies (GEHC) stock from $88 to $84, while maintaining a “Neutral” rating. Despite the lowered price target, the analyst noted strong fundamentals for the broader medical technology sector. GE HealthCare also announced FDA clearance for its new Genesis™ Radiology Workspace viewer, “View,” designed to improve radiology workflow efficiency.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin